Supriya Lifescience schedules virtual investor meeting on Sep 25
- Supriya Lifescience hosts virtual investor meeting on Sep 25, 2026
- Session runs from 11:00 am to 12:00 noon in group format
- Disclosure made under SEBI LODR Regulation 30(6)
- Investor presentation uploaded to exchanges and company website
*this image is generated using AI for illustrative purposes only.
Supriya Lifescience will host a virtual group meeting with analysts and institutional investors on September 25, 2026. The session is scheduled to begin at 11:00 am and conclude at 12:00 noon.
The company notified the Bombay Stock Exchange and the National Stock Exchange of India Limited regarding the schedule. This disclosure aligns with Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Meeting Details
The interaction will take place in a virtual format. Officials from Supriya Lifescience will address queries from the investor group during this one-hour window.
| Meeting Type | Date | Time | Mode |
|---|---|---|---|
| Investors Group Meeting | September 25, 2026 | 11:00 am – 12:00 noon | Virtual |
Investor Presentation
Supriya Lifescience has uploaded the relevant investor presentation to both stock exchanges and its official website. The document is available for public access and review by market participants.
The company noted that the scheduled date is subject to change due to exigencies on the part of the company or the participating analysts and funds.
Historical Stock Returns for Supriya Lifescience
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.44% | +9.39% | +23.59% | +74.57% | +32.90% | +152.07% |
What specific strategic initiatives or financial performance metrics will Supriya Lifescience highlight in its upcoming investor presentation?
How might the insights shared during this virtual meeting influence institutional investor sentiment and short-term stock volatility for Supriya Lifescience?
Are there any pending regulatory approvals or clinical trial results for key products that analysts are likely to probe during the Q&A session?
20
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
